Literature DB >> 25186502

Anti-müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age.

Sezai Sahmay1, Mahmut Oncul, Abdullah Tuten, Abdullah Tok, Abdullah Serdar Acıkgoz, Ismail Cepni.   

Abstract

PURPOSE: To investigate whether serum anti-müllerian hormone (AMH), follicle stimulating hormone (FSH), or antral follicle count (AFC) are predictive for clinical pregnancy in women who underwent IVF cycles at the age of 35 and older
METHODS: A total of 240 consecutive women who underwent IVF cycles at the age of 35 and older were enrolled in this crsoss- sectional study. Pregnant and nonpregnant women were compared.
RESULTS: The median AMH level of pregnant women was higher than non-pregnant women [3.20 (0.63-9.60) vs 1.15 (0.01-14.90) ng/ml, p < 0.001]. On logistic regression analysis, AMH was an independent predictor of clinical pregnancy rate (CPR) (OR 1.353; 95 % CI 1.141-1.605; P < 0.001). After controlling for the other independent variables (the number of retrieved oocytes, AFC and age), the significant association between AMH and clinical pregnancy rate remained strong (OR 1.677; 95 % CI 1.216-2.311; p = 0.002) on multivariate logistic regression analysis.
CONCLUSIONS: AMH is an effective measure of quantitative ovarian reserve and it can predict ovarian response to controlled stimulation for advanced age women. The CPR tends to increase as AMH increases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186502      PMCID: PMC4389927          DOI: 10.1007/s10815-014-0324-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

1.  Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Authors:  Jesper M J Smeenk; Fred C G J Sweep; Gerhard A Zielhuis; Jan A M Kremer; Chris M G Thomas; Didi D M Braat
Journal:  Fertil Steril       Date:  2006-11-01       Impact factor: 7.329

2.  Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.

Authors:  Barbro Fridén; Peter Sjöblom; Judith Menezes
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-10       Impact factor: 2.100

3.  Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.

Authors:  Joana Peñarrubia; Francisco Fábregues; Dolors Manau; Montserrat Creus; Gemma Casals; Roser Casamitjana; Franciso Carmona; Juan A Vanrell; Juan Balasch
Journal:  Hum Reprod       Date:  2005-01-21       Impact factor: 6.918

4.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Authors:  S Lie Fong; J A Visser; C K Welt; Y B de Rijke; M J C Eijkemans; F J Broekmans; E M Roes; W H M Peters; A C S Hokken-Koelega; B C J M Fauser; A P N Themmen; F H de Jong; I Schipper; J S E Laven
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

5.  Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening.

Authors:  G E Hofmann; D R Danforth; D B Seifer
Journal:  Fertil Steril       Date:  1998-03       Impact factor: 7.329

6.  Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.

Authors:  Sezai Sahmay; Gökhan Demirayak; Onur Guralp; Pelin Ocal; Levent M Senturk; Engin Oral; Tulay Irez
Journal:  J Assist Reprod Genet       Date:  2012-04-11       Impact factor: 3.412

7.  One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age.

Authors:  A Lass; C Croucher; S Duffy; K Dawson; R Margara; R M Winston
Journal:  Fertil Steril       Date:  1998-12       Impact factor: 7.329

8.  Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.

Authors:  Janet Kwee; Roel Schats; Joseph McDonnell; Axel Themmen; Frank de Jong; Cornelis Lambalk
Journal:  Fertil Steril       Date:  2007-10-17       Impact factor: 7.329

Review 9.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

Review 10.  The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

Authors:  Simone L Broer; Ben Willem J Mol; Dave Hendriks; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2008-03-05       Impact factor: 7.329

View more
  5 in total

Review 1.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

2.  Pregnancy outcomes after assisted reproductive procedures with embryos that had been derived from affected and unaffected ovaries among women with small unilateral endometriomas.

Authors:  Akiko Takashima; Naoki Takeshita; Toshihiko Kinoshita
Journal:  Reprod Med Biol       Date:  2017-03-22

3.  Recombinant anti-Müllerian hormone in the maturation medium improves the in vitro maturation of human immature (GV) oocytes after controlled ovarian hormonal stimulation.

Authors:  Jure Bedenk; Tadeja Režen; Taja Železnik Ramuta; Nina Jančar; Eda Vrtačnik Bokal; Ksenija Geršak; Irma Virant Klun
Journal:  Reprod Biol Endocrinol       Date:  2022-01-24       Impact factor: 5.211

4.  Expression of Anti-Müllerian Hormone and Its Type 2 Receptor in the Ovary of Pregnant and Cyclic Domestic Cats.

Authors:  Nilgün Gültiken; Murat Yarim; Selim Aslan; Hande Gürler; Gul Fatma Yarim; Müge Tuncay; Sinem İnal; Sabine Schäfer-Somi
Journal:  Animals (Basel)       Date:  2022-03-30       Impact factor: 2.752

Review 5.  The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response.

Authors:  Hyun Jong Park; Geun Ho Lee; Du Sik Gong; Tae Ki Yoon; Woo Sik Lee
Journal:  Clin Exp Reprod Med       Date:  2016-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.